Stock A023910 DAIHAN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Daihan Pharmaceutical Co.,Ltd.

Equities

A023910

KR7023910003

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
28,100 KRW +0.36% Intraday chart for Daihan Pharmaceutical Co.,Ltd. +0.54% +1.26%
2023 Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index CI
2023 Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index
CI
Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.
CI
Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.
CI
Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 28, 2022, has closed with 120,000 shares, representing 2% for KRW 3,418.04 million.
CI
Daihan Pharmaceutical Co.,Ltd. announces an Equity Buyback for 120,000 shares.
CI
Daihan Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
CI
Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) added to S&P Global BMI Index
CI
Hangaram Investment Management Co.,Ltd acquired 5.1% stake in Daihan Pharmaceutical Co.,Ltd..
CI
Daihan Pharmaceutical Co. Ltd. closed an Equity Buyback in the amount of KRW770.46 mm
CI
Daihan Pharmaceutical Co. Ltd. announces an Equity Buyback
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A023910 Stock
  4. News Daihan Pharmaceutical Co.,Ltd.